Evalueserve
DECEMBER 6, 2021
On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. Sponsor deals rebounded exceptionally.
Alpha Sense BI
JUNE 6, 2024
Improved Decision-Making and Risk Management A competitor analysis framework allows you to better anticipate and prepare for competitors’ disruptive moves like price changes, new product launches, or strategic alliances. This allows for more effective contingency planning so you are never caught unawares without a strategy.
Engage3
MAY 19, 2022
He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Kevin also has earned a CSM from Scrum Alliance and a PMC-I from Pragmatic Marketing. He holds B.A.
Expert insights. Personalized for you.
98 
Let's personalize your content